Nuformix PLC Notice of AGM (7165H)
2023年7月31日 - 10:00PM
RNSを含む英国規制内ニュース (英語)
TIDMNFX
RNS Number : 7165H
Nuformix PLC
31 July 2023
Nuformix plc
("Nuformix" or the "Company" or the "Group")
Notice of Annual General Meeting ("AGM")
Nuformix plc (LSE: NFX), a pharmaceutical development company
targeting unmet medical needs in fibrosis and oncology via drug
repurp osing, announces that the 2023 Notice of AGM has today been
posted to its shareholders:
A full pdf version of the Notice of AGM will shortly be
available for download from the Investor Information section on the
Company's website www.nuformix.com .
The AGM will be held on 24 August 2023 at 10.00 am at the
offices of Shakespeare Martineau, 6(th) floor, 60 Gracechurch
Street, London, EC3V 0HR.
Enquiries:
Nuformix plc
Dr Dan Gooding, Executive Director Via IFC Advisory
Stanford Capital Partners Limited
Tom Price / Patrick Claridge (Corporate
Finance) +44 (0) 20 3650 3650
John Howes / Bob Pountney (Corporate
Broking) +44 (0) 20 3650 3652
IFC Advisory Limited
Tim Metcalfe +44 (0) 20 3934 6630
Zach Cohen nuformix@investor-focus.co.uk
About Nuformix
Nuformix is a pharmaceutical development company targeting unmet
medical needs in fibrosis and oncology via drug repurposing. The
Company aims to use its expertise in discovering, developing and
patenting novel drug forms, with improved physical properties, to
develop new products in new indications that are, importantly,
differentiated from the original (by way of dosage, delivery route
or presentation), thus creating new and attractive commercial
opportunities. Nuformix has a pipeline of pre-clinical assets with
potential for significant value and early licensing
opportunities.
For more information, please visit www.nuformix.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOADFLBXXDLLBBD
(END) Dow Jones Newswires
July 31, 2023 09:00 ET (13:00 GMT)
Nuformix (LSE:NFX)
過去 株価チャート
から 5 2024 まで 6 2024
Nuformix (LSE:NFX)
過去 株価チャート
から 6 2023 まで 6 2024